Biotech and telecom:

Unique Swedish technology raises 30 MSEK from Investor and
Innovationskapital

Åmic AB has raised 30 MSEK in a new share emission backed by Investor
Growth Capital, a wholly owned subsidiary of Investor AB, and
Innovationskapital. The Uppsala based company has developed unique
technology and know-how for manufacturing microsystems & components in
the biotechnology and telecom markets.

The new funds will be used to build up Åmic´s production capacity and to
strengthen International marketing activities.

- We believe Åmic´s patented technology and know-how has great potential
in several applications and is an excellent fit to many of our Biotech
investments. We see Åmic as a key partner for a range of players in the
global Biotechnology and Telecom markets, says Michael Horal, Managing
Director, Investor Growth Capital.

Unique Technology
Using Åmic´s patented technology and know-how, three-dimensional
microstuctures can be mass produced in plastic materials with critical
dimensions less than a thousandth of a millimetre. An original of the
microstructure is first manufactured using methods derived from the
silicon-IC industry. The original is then copied to a mould, which is
used to mass produce plastic microstructures using methods similar to
the production of CD or DVD optical discs.

-What makes Åmic particularly interesting from an investors´ viewpoint
is the breadth of their technology and the expertise in the company,
says Staffan Ingeborn, InnovationsKapital´s CEO.

Adding Industrial Expertise
Åmic has put together a combination of tried and tested manufacturing
methods in a unique production platform for plastic microstructures.

- Investor Growth Capital´s and Innovationskapital´s engagement in Åmic
will give us an important injection of industrial expertise and
strengthen our development process. We plan to intensify our efforts on
the export market; demand for our products and services is particularly
good in the USA, says Björn Berg, Åmic´s CEO.

Biotechnology and Telecom
Åmic´s technology platform has applications in both the Biotech &
telecom markets. Since 1998, when the company was founded by Ove Öhman
and Gunnar Axe, Åmic has had a number of successful collaborations with
customers and research institutes in both market segments. Amongst
Åmic´s customers are Scandinavian companies such as Biacore,
Pyrosequencing, Gyros, Cellectricon, Nokia, Gnothis, Senseair och
Uppsala Universitet, plus a growing number of customers in the USA and
Germany.

Revenue...